✦ LIBER ✦

Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib

✍ Scribed by Haouala, A.; Widmer, N.; Duchosal, M. A.; Montemurro, M.; Buclin, T.; Decosterd, L. A.

Book ID: 111901355
Publisher: American Society of Hematology
Year: 2011
Tongue: English
Weight: 103 KB
Volume: 117
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2010-07-294330

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adverse cutaneous reactions secondary to

Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib

✍ IRIS AMITAY-LAISH; SALOMON M. STEMMER; MARIO E. LACOUTURE 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

Simple methodology for the therapeutic d

Simple methodology for the therapeutic drug monitoring of the tyrosine kinase inhibitors dasatinib and imatinib

✍ M. Birch; P. E. Morgan; S. Handley; A. Ho; R. Ireland; R. J. Flanagan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 734 KB

Target spectrum of the BCR-ABL inhibitor

Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib

✍ Hantschel, Oliver; Rix, Uwe; Superti-Furga, Giulio 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 441 KB

The BCR/ABL-inhibitors imatinib, nilotin

The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity

✍ Julia Salih; Julia Hilpert; Theresa Placke; Frank Grünebach; Alexander Steinle; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 937 KB

## Abstract In chronic myeloid leukemia (CML), BCR/ABL‐mediated oncogenic signaling can be targeted with the BCR/ABL‐inhibitors Imatinib, Nilotinib and Dasatinib. However, these agents may also affect anti‐tumor immunity. Here, we analyzed the effects of the 3 BCR/ABL‐inhibitors on natural killer (

Gene expression signatures associated wi

Gene expression signatures associated with the in vitro resistance to two tyrosine kinase inhibitors, nilotinib and imatinib

✍ Kim, T-M; Ha, S-A; Kim, H K; Yoo, J; Kim, S; Yim, S-H; Jung, S-H; Kim, D-W; Chun 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 647 KB

Comparative suppressive effects of tyros

Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis

✍ Naotsugu Akashi; Isao Matsumoto; Yoko Tanaka; Asuka Inoue; Kayo Yamamoto; Naoto 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 527 KB